Featured Research

from universities, journals, and other organizations

Cell study offers more diabetic patients chance of transplant

Date:
August 29, 2013
Source:
University of Edinburgh
Summary:
Diabetic patients could benefit from a breakthrough that enables scientists to take cells from the pancreas and change their function to produce insulin. The research could reduce waiting times for patients with type 1 Diabetes who need islet cell transplants. These transplants are carried out to prevent life-threatening complications resulting from diabetes, such as seizures resulting from low blood sugar levels.

Diabetic patients could benefit from a breakthrough that enables scientists to take cells from the pancreas and change their function to produce insulin.

The research could reduce waiting times for patients with Type 1 Diabetes who need islet cell transplants. These transplants are carried out to prevent life-threatening complications resulting from diabetes, such as seizures resulting from low blood sugar levels.

Islet cells -- which occur naturally in the pancreas -- produce insulin, which enables the body to store glucose. However, not enough of these cells can be provided by a single donor for a successful islet transplant to take place.

This means that patients can wait months before a second pancreas becomes available so that a sufficient number of islet cells to be transplanted.

The breakthrough, published in the journal Diabetes, could enable pancreatic cells -- other than islets -- to be developed in the laboratory for transplant operations.

It was carried out by the University of Aberdeen, the Medical Research Council Centre for Regenerative Medicine at the University of Edinburgh and the Scottish National Blood Transfusion Service.

Only one pancreas donation would be needed to enable the successful transplantation of insulin-producing cells, which would save months waiting for a second donor to become available as well as make more organs available for other patients.

This would involve an islet cell transplant once an organ becomes available, followed by a second transplant soon after when enough pancreatic cells have been developed to produce insulin.

The effects of the operations would also be longer lasting than currently as more cells would be transplanted.

Islet cell transplants are given to Type 1 diabetics -- who are unable to make insulin and are dependent on insulin injections -- to treat severe hypoglycemic unawareness.

This condition can cause potentially fatal seizures as patients have no warning signals that their blood sugar has reached dangerously low levels.

Almost 20 per cent of patients with Type 1 diabetes suffer from hypoglycemic unawareness.

John Casey, of the University of Edinburgh and also lead clinician for the National Islet Transplant Programme in Scotland, said: "There is a shortage of organ donors, which is not helped by the need for two pancreases to be donated to treat each patient. Developing previously unusable cells to produce insulin means that fewer donors would be needed, which would make a huge difference to patients waiting for transplants operations."

The research was funded by the Medical Research Council.

Professor Kevin Docherty, of the University of Aberdeen, said: "This is an example of how reprogramming, -- the ability to change one cell type into another -- can have a huge impact on the development of cell based therapy for diabetes and many other diseases."

An islet cell transplant programme was introduced in the UK in 2008. Since then, over 90 islet transplants have been successfully carried out in the UK with some patients now completely free of insulin injections.


Story Source:

The above story is based on materials provided by University of Edinburgh. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. J. Lima, K. R. Muir, H. M. Docherty, R. Drummond, N. W. A. McGowan, S. Forbes, Y. Heremans, I. Houbracken, J. A. Ross, S. J. Forbes, P. Ravassard, H. Heimberg, J. Casey, K. Docherty. Suppression of Epithelial-to-Mesenchymal Transitioning Enhances Ex Vivo Reprogramming of Human Exocrine Pancreatic Tissue Toward Functional Insulin-Producing -Like Cells. Diabetes, 2013; 62 (8): 2821 DOI: 10.2337/db12-1256

Cite This Page:

University of Edinburgh. "Cell study offers more diabetic patients chance of transplant." ScienceDaily. ScienceDaily, 29 August 2013. <www.sciencedaily.com/releases/2013/08/130829110200.htm>.
University of Edinburgh. (2013, August 29). Cell study offers more diabetic patients chance of transplant. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2013/08/130829110200.htm
University of Edinburgh. "Cell study offers more diabetic patients chance of transplant." ScienceDaily. www.sciencedaily.com/releases/2013/08/130829110200.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins